SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Alpha's work is substantial and interesting but IMHO

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
meirluc Member Profile
 
Followed By 0
Posts 143
Boards Moderated 0
Alias Born 02/01/17
160x600 placeholder
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/15/2017 4:12:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/8/2017 5:28:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 5:24:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/7/2017 5:19:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 1:14:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/26/2017 3:21:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 5:17:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/29/2017 4:27:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/27/2017 5:02:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/19/2017 5:20:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/13/2017 5:08:50 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 6/1/2017 10:28:04 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/31/2017 7:37:55 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/26/2017 5:23:00 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 5/17/2017 11:54:01 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:35:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/25/2017 5:12:52 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/17/2017 5:26:07 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 4/17/2017 3:36:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/7/2017 2:33:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/5/2017 5:17:05 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/31/2017 5:28:50 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 3/24/2017 4:38:38 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 3/24/2017 4:32:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/23/2017 5:02:14 PM
meirluc   Saturday, 08/12/17 11:14:49 AM
Re: None
Post # of 130251 
Alpha's work is substantial and interesting but IMHO the blended mOS of 17.7 months (15 months for control, 19 for trial) is a bit too short. The blended 30% OS of the NWBO trial would be about 38 months if the 233rd event happened last months and longer if it has not yet occurred. The Optune+TMZ+RT curve shows a shorter 30% OS of only about 33 months, yet the mOS of that trial is 20.9 months. This suggests to me that the blended mOS of the NWBO trial will be a few months longer than 20.9 months and I am guessing at a 23-25 months blended mOS with a control mOS of 19-21 months and a trial mOS of 25-27 months.

Furthermore, a 17.7 months blended mOS would have roughly occurred around 11/15, 18 months after the midpoint enrollment of May 2014 (5/14) and about 13 months before we even reached the 75% progression point which may have occurred around 12/16. I have not seen trials where 50% of the trial's fatalities preceded the 75% progression event by more than a year. This also suggests to me that the blended mOS event in the NWBO trial occurred months after 11/15 and extends well over 20 months.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist